Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT
Giugliano RP, Cannon CP, Blazing MA, et al.
Circulation. Originally published December 20, 2017
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Best Friend or Spy: A Qualitative Meta-Synthesis on The Impact of Continuous Glucose Monitoring on Life With Type 1 Diabetes
Messer LH, Johnson R, Driscoll KA et al.
Diabetic Medicine. Accepted manuscript online 16 Dec 2017
Leggi
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes
Sberna AL, Bouillet B, Rouland A, et al.
Diabetic Medicine. Accepted manuscript online 16 Dec 2017
Leggi
Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity from 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults
NCD Risk Factor Collaboration (NCD-RisC)
The Lancet. 2017;390:2627-42
Leggi
Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes
Wei Ting DS, Yim-Lui Cheung C, Lim G, et al.
JAMA. 2017;318(22):2211-23
Leggi
Menopausal Hormone Therapy for Primary Prevention of Chronic Disease. US Preventive Services Task Force Recommendation Statement
Lewis CE, Wellons MF
JAMA. 2017;318(22):2187-9
Leggi
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
Garg SK, Henry RR, Banks P, et al.
N Engl J Med 2017;377:2337-48
Leggi
Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit
Heald H, Livingston M, Fryer A, et al.
Diabet Med. Pub online 10 December 2017
Leggi
Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
Mostafa SA, Coleman RL, Agbaje OF, et al.
Diabet Med 2018;35(1):72-7
Leggi
Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital
Marjot T, Sbardella E, Moolla A, et al.
Diabet Med. Pub. online 10 December 2017
Leggi